These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15575068)

  • 21. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insurgent micrometastases: sleeper cells and harboring the enemy.
    Wieder R
    J Surg Oncol; 2005 Mar; 89(4):207-10. PubMed ID: 15726617
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating tumor cells in patients with breast cancer dormancy.
    Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
    Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
    Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
    Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method.
    Tkaczuk KH; Goloubeva O; Tait NS; Feldman F; Tan M; Lum ZP; Lesko SA; Van Echo DA; Ts'o PO
    Breast Cancer Res Treat; 2008 Sep; 111(2):355-64. PubMed ID: 18064568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "microscopic" revolution in breast carcinoma.
    Cristofanilli M
    Cancer; 2005 Mar; 103(5):877-80. PubMed ID: 15611972
    [No Abstract]   [Full Text] [Related]  

  • 31. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional Resection in Stage IV breast cancer: tumor biology, molecular and clinical perspectives.
    Lang JE; Babiera GV
    Surg Clin North Am; 2007 Apr; 87(2):527-38, xi-xii. PubMed ID: 17498542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
    Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combinatorial approach to the selective capture of circulating malignant epithelial cells by peptide ligands.
    Aggarwal S; Janssen S; Wadkins RM; Harden JL; Denmeade SR
    Biomaterials; 2005 Oct; 26(30):6077-86. PubMed ID: 15907998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating and disseminated tumor cells in the management of breast cancer.
    Ross JS; Slodkowska EA
    Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
    Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
    Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells in breast cancer: blood will tell.
    Sledge GW
    Clin Cancer Res; 2006 Nov; 12(21):6321-2. PubMed ID: 17085639
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer stem cells in breast cancer and metastasis.
    Lawson JC; Blatch GL; Edkins AL
    Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells in breast cancer: fiction or reality?
    Cristofanilli M; Reuben J; Uhr J
    J Clin Oncol; 2008 Jul; 26(21):3656-7; author reply 3657-8. PubMed ID: 18640950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.